Your Health, We Care
Fidaxomicin, as an important antibacterial drug, holds a certain market share in the global market. With the deepening understanding of Clostridium difficile infection and the increasing demand for treatment, the market prospects of non fungicide are broad.
Fidaxomicin is a white to off-white film-coated oblong tablet and should be used···【more】
Release date：2024-08-28Recommended：121
Fidaxomicin works by inhibiting the RNA polymerase of bacteria, which has little···【more】
Release date：2024-08-28Recommended：144
Fidaxomicin is a macrolide antibiotic developed by Optimer and approved by the F···【more】
Release date：2024-08-28Recommended：159
Fidaxomicin received its initial approval from the Food and Drug Administration ···【more】
Release date：2024-08-05Recommended：109
